Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy-Reference-Cited by-同舟云学术

Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy

Published:2014-05-29 Issue:1 Volume:14 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Yashi Masahiro,Mizuno Tomoya,Yuki Hideo,Masuda Akinori,Kambara Tsunehito,Betsunoh Hironori,Abe Hideyuki,Fukabori Yoshitatsu,Muraishi Osamu,Suzuki Koyu,Nakazato Yoshimasa,Kamai Takao

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2490-14-43.pdf

Reference38 articles.

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.

2. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators: Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012, 366: 981-990. 10.1056/NEJMoa1113135.

3. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, Soda M, Ioka A, Sobue T, Nishimoto H: An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol. 2013, 43: 492-507. 10.1093/jjco/hyt038.

4. Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Bill-Axelson A, SPCG-4 Investigators: Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011, 12: 891-899. 10.1016/S1470-2045(11)70162-0.

5. Ahmed HU, Arya M, Freeman A, Emberton M: Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?. Lancet Oncol. 2012, 13: e509-e517. 10.1016/S1470-2045(12)70388-1.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy;Archives of Pathology & Laboratory Medicine;2022-01-12

2. Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer;The Korean Journal of Urological Oncology;2020-08-31

3. Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization;Modern Pathology;2020-04-01

4. Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization;2019-10-25

5. Elevated Serum Sialic Acid Levels Predict Prostate Cancer As Well As Bone Metastases;Journal of Cancer;2019